Recent progress in the molecular genetic aspects of non-insulin-dependent diabetes mellitus

Internal Medicine

Volumn 35, Issue 5, 1996, Pages 347-355

  Seino, Susumu ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Candidate genes; Diabetes mellitus; Genetics; Insulin; Positional cloning

Indexed keywords

GLUCOKINASE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 2; INSULIN; INSULIN RECEPTOR; MITOCHONDRIAL DNA;

BIOLOGICAL MODEL; DISEASE PREDISPOSITION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; MOLECULAR CLONING; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PHYSIOLOGY; REVIEW; SECRETION; SIGNAL TRANSDUCTION;

AGE OF ONSET; BLOOD GLUCOSE; CLONING, MOLECULAR; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; DNA, MITOCHONDRIAL; GENETIC HETEROGENEITY; GLUCOKINASE; GLUCOSE TRANSPORTER TYPE 2; HUMANS; INSULIN; LINKAGE (GENETICS); MODELS, GENETIC; MONOSACCHARIDE TRANSPORT PROTEINS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0030137368     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.347     Document Type: Review

References (113)

1. Hamman RF. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes/Metab. Rev 8: 287, 1992.
2. DeFronzo RA, Bonadonna RC, Ferrannini, E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15: 318, 1992.
3. Reaven GM. Role of insulin resistance in human disease. Diabetes 37: 1595, 1988.
4. Olefsky JM. Insulin resistance and insulin action: an in vitro and in vivo perspective. Diabetes 30: 148, 1981.
5. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066, 1994.
6. Porte D. β-cells in type II diabetes mellitus. Diabetes 40: 166, 1991.
7. O'Rahilly S, Turner RC, Matthews DR. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318: 1225, 1988.
8. O'Meara NM, Sturis J, van Cauter E, Polonsky KS. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest 92: 262, 1993.
9. Mitrakou A, Kelley D, Mokan M, et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 216: 22, 1992.
10. Foster DW. Diabetes mellitus. in: Metabolic Basis of Inherited Disease, Scriber CR, Beaudet AL, Sly WS, Valle D., Eds. 6th ed, vol I, McGraw-Hill, New York, 1989, p.375.
11. Bennett PH. Epidemiology of diabetes mellitus. in: Diabetes Mellitus: Theory and Practice, Rifkin D, Porte D, Eds. Elsevier, New York, 1990, p.357.
12. Kobberling J, Tillil H. Empirical risk figures for first degree relatives of non-insulin dependent diabetes. in: The Genetics of Diabetes Mellitus, Kobberling J, Tattersall R, Eds. Academic Press, London, 1982, p.201.
13. Rotter JI, Vadheim CM, Rimoin DL. Genetics of diabetes mellitus. in: Diabetes Mellitus: Theory and Practice, Rifkin D, Porte D, Eds. Elsevier, New York, 1990, p.378.
14. O'Rahilly S, Wainscoat JS, Turner RC. Type 2 (non-insulin-dependent) diabetes mellitus: new genetics for old nightmares. Diabetologia 31:407, 1988.
15. McCarthy MI, Froguel P, Hitman GA. The genetics of non-insulin-dependent diabetes mellitus: tool and aims. Diabetologia 37: 959, 1994.
16. Fajans SS. Maturity-onset diabetes of the young (MODY). Diabetes/Metab Rev 13: 49, 1989.
17. Emery AEH. Methodology in Medical Genetics: An Introduction to Statistical Methods. Churchill Livingston, Edinburgh, 1986, p.114.
18. Cox NJ, Bell GI. Disease associations: chance, artifact, or susceptibility genes? Diabetes 38: 947, 1989.
19. Bell GI, Wu S, Newman M, et al. Diabetes mellitus: Identification of susceptibility genes, in: Etiology of Human Disease at the DNA Level, Lindsten J, Pettersson U, Eds. Raven Press, New York, 1991, p.93.
20. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 265: 2037, 1994.
21. Rommens JM, Iannuzzi MC, Kerem B-S, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059, 1989.
22. Riordan JR, Rommens JM, Kerem B-S, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066, 1989.
23. Kerem BS, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073, 1989.
24. Kinzler KW, Nilbert MC, Su L-K, et al. Identification of FAP locus genes from chromosome. Science 253: 661, 1991.
25. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589, 1991.
26. Davies JL, Kawaguchi Y, Bennett ST, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130, 1994.
27. Collins FS. Positional cloning: Let's not call it reverse anymore. Nature Genet 1:3, 1992.
28. Wollheim CB, Sharp GWG. Regulation of insulin release by calcium. Physiol Rev 61: 914, 1981.
29. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67: 1185, 1987.
30. 2+, cAMP and diacylglycerol. Mol Cell Endocrinol 70: 119, 1990.
31. Ashcroft SJH, Bassett JM, Rande PJ. Insulin secretion mechanisms and glucose metabolism in isolated islets. Diabetes [Suppl 2] 21: 538, 1972.
32. Sener A, Malaisse WJ. Nutrient metabolism in islet cells. Experimentia 40: 1026, 1984.
33. Meglasson MD, Matshinsky FM. New perspectives on pancreatic glucokinase. Am J Physiol 246: El, 1984.
34. Ashcroft FM. Adenosine 5'-triphosphate-sensitive potassium channels. Ann Rev Neurosci 11: 97, 1988.
35. Abel ED, Houseknecht KL, Kahn B, Recent advances in understanding the molecular basis for insulin-stimulated glucose transport. Curr Opin Endocrinol 2: 313, 1995.
36. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocrine Rev 16: 117, 1995.
37. Backer JM, Myers MG Jr, Shoelson SE, et al. The phosphatidyl-inositol 3-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11: 4369, 1992.
38. Hara K, Yonezawa K, Sakaue H, et al. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA 91: 7415, 1994.
39. Cheatham B, Vlahos C, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14: 4902, 1994.
40. Bell GI, Xiang K, Newman MV, Wu S, et al. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 88: 1484, 1991.
41. Vaxillaire M, Boccio V, Philippi A, et al. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genet 9: 418, 1995.
42. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman M. Positional cloning of the mouse obese gene and its human homologue. Nature 373: 425, 1994.
43. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967, 1992.
44. Bell GI, Pictet RL, Rutter WJ, Cordell B, Tischer E, Goodman HM. Sequence of the human insulin gene. Nature 284: 26, 1980.
45. Harper ME, Ullrich A, Saunders GF. Localization of the human insulin gene to the distal end of the short arm of chromosome 11. Proc Natl Acad Sci USA 78: 4458, 1981.
46. Steiner DF, Tager HS, Chan SJ, Nanjo K, Sanke T, Rubenstein AH. Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care 13: 600, 1990.
47. Yano H, Kitano N, Morimoto M, Polonsky KS, Imura H, Seino Y. A novel point mutation in the human insulin gene givingrise to hyperproinsulinemia (proinsulin Kyoto). J Clin Invest 89: 1902, 1992.
48. Schwartz GP, Burke SGT, Katsoyannis PG. A superactive insulin: [B10-aspartic acid] insulin (human). Proc Natl Acad Sci USA 84: 6408, 1987.
49. Olansky L, Welling C, Giddings S, et al. A variant insulin promoter in non-insulin-dependent diabetes mellitus. J Clin Invest 89: 1596, 1992.
50. Kahn CR., Flier JS, Bar RS, et al. The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N Engl J Med 294: 739, 1976.
51. Ullrich A, Bell JR, Chen EY, et al. Human insulin receptor, its relationship to the tyrosine kinase family of oncogenes. Nature 313: 756, 1985.
52. Ebina Y, Ellis L, Jarnagin K, et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40: 747, 1985.
53. Seino S, Seino M, Nishi S, Bell GI. Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci USA 86: 114, 1989.
54. Yang-Feng TL, Francke U, Ullrich A. Gene for human insulin receptor: localization to site on chromosome 19 involved in pre-β-cell leukemia. Science 228: 728, 1985.
55. Yoshimasa Y, Seino S, Whittaker J, et al. Insulin resistant diabetes due to a point mutation that prevents insulin receptor processing. Science 240: 784, 1988.
56. Kadowaki T, Bevins CL, Cama A, et al. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240: 787, 1988.
57. Seino S, Seino M, Bell GI. Human insulin-receptor gene: partial sequence and amplification of the exons by the polymerase chain reaction. Diabetes 39: 23, 1990.
58. Taylor S, Cama A, Accili D, et al. Mutations in the insulin receptor gene. Endocrine Rev 13: 566, 1992.
59. Matsutani A, Janssen R, Donis-Keller H, Permutt MA. A polymorphic (CA)n repeat element maps the human glucokinase gene (GCK) to chromosome 7p. Genomics 12: 319, 1992.
60. Stoffel M, Froguel P, Takeda J, et al. Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci 89: 7698, 1992.
61. Tanizawa Y, Koranyi LI, Welling CM, Permutt MA. Human liver glucokinase gene: cloning and sequence determination of two altematively spliced cDNA. Proc Natl Acad Sci 88: 7294, 1991.
62. Tanizawa Y, Mastsutatni A, Chiu KC, Permutt MA. Human glucokinase gene: isolation, structural characterization, and identification of a microsatellite repeat polymorphism. Mol Endocrinol 6: 1070, 1992.
63. Magnuson MA. Glucokinase gene structure: functional implications of molecular studies. Diabetes 39: 523, 1990.
64. Printz RL, Magnuson MA, Granner DK. Mammalian glucokinase. Annu Rev Nutr 13: 463, 1993.
65. Froguel P, Vaxillaire M, San F, et al. Clone linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356: 162, 1992.
66. Vionnet N, Stoffel M, Takeda J, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356: 721, 1992.
67. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase. N Engl J Med 328: 697, 1993.
68. Permutt MA, Chiu KC, Tanizawa Y. Perspective in diabetes glucokinase and NIDDM. A candidate gene that paid off. Diabetes 41: 1367, 1992.
69. Stoffel M, Bell KL. Blackburn CL, et al. Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Diabetes 42: 937, 1993.
70. Zouali H, Vaxillaire M, Lesage S, et al. Linkage analysis and molecular scanning of glucokinase gene in NIDDM families. Diabetes 42: 1238, 1993.
71. Katagiri H, Asano T, Ishihara H, et al. Non sense mutation glucokinase gene in late-onset non-insulin-dependent diabetes mellitus. Lancet 340: 1316, 1992.
72. Shimada F, Makino H. Hashimoto N, et al. Type 2 (non-insulin-dependent) diabetes mellitus associated with a mutation of the glucokinase gene in a Japanese family. Diabetologia 36: 433, 1993.
73. Stoffel M, Patel P, Lo Y, et al. Missense glucokinase mutation in maturityonset diabetes of the young and mutation screening in late-onset diabetes. Nature Genet 2: 153, 1992.
74. Takeda J, Gidh-Jain M, Xu LZ, et al. Structure/function studies of human β-cell glucokinase: enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants. J Biol Chem 268: 15200, 1993.
75. Wallace DC. Mitochondrial genetics: a paradigm for aging an degenerative diseases? Science 256: 628, 1992.
76. Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet 1: 11, 1992.
77. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet 1: 368, 1992.
78. Reardon W, Ross RJM, Sweeney MG. et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376, 1992.
79. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330: 962, 1994.
80. Burant CF. Sicitz WI, Fukumoto H, et al. Mammalian glucose transporters: structure and molecular regulation. Recent Prog Horm Res 47: 349, 1991.
81. Johnson JH, Ogawa A, Chen L, et al. Underexpression on beta-cell high Km glucose transporters in non-insulin-dependent diabetes. Science 250: 546, 1990.
82. Thorens B, Weir GC, Leahy JL, Bonner-Weir S. Reduced expression of the liver/beta-cell glucose transporter isoform in glucose-insensitive pancreatic beta-cells of diabetic rats. Proc Natl Acad Sci USA 87: 6492, 1990.
83. Patel P, Bell GI, Cook JTE, Turner RC, Wainscoat JS. Multiple restriction fragment length polymorphisms at the GLUT2 locus: GLUT2 haplotypes for genetic analysis of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 817, 1991.
84. Elbein SC, Hoffman MD, Matsutani A, Permutt MA. Linkage analysis of Glut (HepG2) and Glut2 (liver/islet) genes in familial NIDDM. Diabetes 41: 1660, 1992.
85. 1 subunit of a voltage-dependent calcium channel expressed in pancreatic β-cells. Proc Natl Acad Sci USA 89: 584, 1992.
86. 1 subunit (CACNL 1A2) and β subunit (CACNLB3) genes. Genomics 27: 312, 1995.
87. Inagaki N, Gonoi T, Clement JP IV, et al. Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270: 1166, 1995.
88. Westermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827, 1986.
89. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628, 1987.
90. Nishi M, Sanke T, Nagamatsu S, Bell GI, Steiner DF. Islet amyloid polypeptide. J Biol Chem 265: 4173, 1990.
91. Cook JTE, Patel PP, Clark A, et al. Non-linkage of the islet amyloid polypeptide gene with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 103, 1991.
92. Nishi M, Bell GI, Steiner DF. Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non insulin dependent) diabetic patients. Diabetologia 33: 628, 1990.
93. Thorens B. Expression cloning of the pancreatic β-cell receptor for the gluco-incretin hormone glucagon-like peptide-l. Proc Natl Acad Sci USA 89: 8641, 1992.
94. Yamada Y, Hayami T, Nakamura K, et al. Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. Genomics 29: 773, 1995.
95. Ebert R, Creutzfeld W. Gastrointestinal peptides and insulin secretion. Diabetes/Metab Rev 3: 1, 1987.
96. Fukumoto H, Kayano T, Buse JB, et al. Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem 264: 7776, 1989.
97. Buse JB, Yasuda K, Lay TP, Seo, et al. Human GLUT4/Muscle-fat glucose-transporter gene. Diabetes 41: 1436, 1992.
98. Eriksson J, Franssila-Kakkunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337, 1989.
99. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223, 1989.
100. Groop LC, Kankuri M, Schalin-Jantti C, Lindlof C. Association between polymorphism of the glycogen synthase gene and non-insulin dependent diabetes mellitus. N Engl J Med 328: 10, 1993.
101. BjØrbæk C, Echwald SM, Hubricht P, et al. Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. Diabetes 43: 976, 1994.
102. Elbein SC, Hoffman M, Ridinger D, Otterud B, Leppert M. Description of a second microsatellite marker ad linkage analysis of the muscle glycogen synthase locus in familial NIDDM. Diabetes 43: 1061, 1994.
103. Hager J, Zouali H, Velho G, Froguel P. Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families. Lancet 342: 1430, 1993.
104. Laakso M, Malkki M. Kekäläinen P, Kuusisto J, Deeb SS. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94: 1141. 1994.
105. Imai Y, Fusco A, Suzuki Y, et al. Variant sequences of insulin receptor substrate-1 in patients with non-insulin-dependenl diabetes mellitus. J Clin Endocrinol Metab 79: 1655, 1994.
106. Hitman G, Hawrami K, McCarthy M, et al. Insulin receptor substrate-1 gene. Diabetogia 38: 481, 1995.
107. Pelleynounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540, 1995.
108. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543, 1995.
109. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central networks. Science 269: 546, 1995.
110. 3-adrenergic-receptor gene. N Engl J Med 333: 343, 1995.
111. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333: 348, 1995.
112. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333: 352, 1995.
113. Collins FS. Positional cloning moves from perditional to traditional. Nature Genet 9: 347, 1995.